A Summary of European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs: Japanese Translation by Japanese Society of Phlebology and Japanese Society for Vascular Surgery
Masayuki Hirokawa, Yoshiko Watanabe(Kawasaki Medical School), Hiroko Kume(Tsukuba Medical Center Hospital), Nobuhiro Shimabukuro, Noriyuki Miyama(Kansai Medical University), Koji Maeda(International University of Health and Welfare), Takashi Kobata(Kanazawa Medical University), Nobuyoshi Azuma(Asahikawa Medical University), Toshio Takayama(The University of Tokyo), Eiichi Teshima(Uji Hospital), Akihiro Hosaka, Tsuyoshi Shimizu(Nagano Matsushiro General Hospital), Toshiya Nishibe(Sapporo Medical University), Hiroko Nemoto(Cardiovascular Institute Hospital), Yutaka Hosoi(Kyorin University), Kensuke Takeuchi, Nozomu Shirasugi(Emory University), Kunihiro Shigematsu(Mita Hospital), Makoto Mo(Yokohama Minami Kyosai Hospital)
Cited by 0
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
Heterologous immunity provides a potent barrier to transplantation tolerance
|Journal of Clinical Investigation|2003|571
Heterologous immunity provides a potent barrier to transplantation tolerance
|Journal of Clinical Investigation|2003|548